logo

Ideaya Biosciences (IDYA)



Trade IDYA now with
  Date
  Headline
11/9/2022 4:29:05 PM Wedbush Is Increasing IDEAYA Biosciences (IDYA) FY22 Rev. Estimate To 55.9 M From 35.2 M
11/9/2022 4:28:31 PM Wedbush Is Raising IDEAYA Biosciences (IDYA) FY22 Estimate To -1.44 From -2.17
11/9/2022 4:28:14 PM Wedbush Is Raising IDEAYA Biosciences (IDYA) Q4 22 Estimate To -0.46 From -0.60
11/9/2022 4:27:30 PM Wedbush Reiterates IDEAYA Biosciences (IDYA) At Outperform With $26 Price Target
11/8/2022 6:09:50 AM IDEAYA Biosciences Q3 Net Income $1.6 Mln Vs. Net Loss $22.1 Mln Last Year
10/18/2022 6:09:12 AM IDEAYA Biosciences Announces Clinical Program Updates For IDE397
9/6/2022 6:05:33 AM IDEAYA Dose\es First-Patient-In For Phase I Trial Of Darovasertib Monotherapy In (Neo)Adjuvant Uveal Melanoma
8/29/2022 6:04:54 AM IDEAYA Biosciences Achieves Preclinical Development Milestone In Ongoing Collaboration With GSK
8/15/2022 6:02:31 AM IDEAYA Biosciences Q2 Loss Per Share $0.57 Vs Loss $0.36 Last Year
7/27/2022 6:06:33 AM IDEAYA Announces IDE397 Program Update And CtDNA Molecular Responses Demonstrating Tumor Pharmacodynamic Modulation
7/27/2022 6:02:00 AM IDEAYA Collaborates With Amgen To Evaluate MAT2A-PRMT5 Synthetic Lethality Combination In MTAP Deleted Tumors
6/28/2022 6:04:56 AM IDEAYA Announces Selection Of Potential First-in-class Pol Theta Helicase Development Candidate
5/10/2022 6:13:10 AM IDEAYA Biosciences Q1 Net Loss $14.0 Mln Vs Net Losss $18.2 Mln Last Year